TY - JOUR AU - Gianotti, Nicola AU - Poli, Andrea AU - Nozza, Silvia AU - Galli, Laura AU - Galizzi, Nadia AU - Ripa, Marco AU - Merli, Marco AU - Carbone, Alessia AU - Spagnuolo, Vincenzo AU - Lazzarin, Adriano AU - Castagna, Antonella PY - 2017 DA - 2017/11/16 TI - Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients JO - BMC Infectious Diseases SP - 723 VL - 17 IS - 1 AB - Switch strategies based on rilpivirine/tenofovir/emtricitabine or on an integrase inhibitor (InSTI) plus tenofovir/emtricitabine have never been compared in randomized clinical trials. The main aim of the study was to investigate the durability of these two switch regimens in virologically suppressed, HIV-infected patients. SN - 1471-2334 UR - https://doi.org/10.1186/s12879-017-2831-9 DO - 10.1186/s12879-017-2831-9 ID - Gianotti2017 ER -